Regalis Life Sciences Private Limited
About Regalis Life Sciences Private Limited
Data last updated:
Regalis Life Sciences Private Limited is a private limited company based in Raipur, Chhattisgarh, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 05 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24304CT2016PTC007375. Its GSTIN is 22AAHCR9024K1Z9 (Chhattisgarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Komal Chand Chopda and Rishabh Chopda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.11 Kedia Business Park Opposite National Garage Tatibandh, Raipur, Chhattisgarh, India – 492001.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.46 Lakh, a decline of 58% compared to the previous year. For the same year it recorded a net profit of ₹81,046 (net margin 1.6%) and EBITDA of ₹1.01 Lakh (EBITDA margin 2%). Revenue has declined at a compounded annual rate (CAGR) of 50% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Regalis Life Sciences Private Limited's registered office is in Raipur, Chhattisgarh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.11 Kedia Business Park Opposite National Garage Tatibandh, Raipur, Chhattisgarh, India – 492001
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Regalis Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Regalis Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Regalis Life Sciences Private Limited, buy the company report.
Financials of Regalis Life Sciences Private Limited
FY 2025 filings availableRegalis Life Sciences Private Limited reported revenue of ₹51.46 Lakh (down 58% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 50% over three years, including a 58% fall in the latest year. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹81,046 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Regalis Life Sciences Private Limited, buy the company report.
Board of directors of Regalis Life Sciences Private Limited
Regalis Life Sciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komal Chand Chopda Also directs: Rishabh Laboratories Pvt Ltd | Director | 05 Jul 2016 | 10 Years 3 Months | Current |
| Rishabh Chopda | Director | 12 Oct 2019 | 7 Years 0 Months | Current |
| Ashish Chopda | Director | 12 Oct 2019 | 7 Years 0 Months | Current |
Auditor
Regalis Life Sciences Private Limited is audited by G S G & ASSOCIATES LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G S G & ASSOCIATES LLP | FY 2022 | C400015 |
Shareholding
The shareholding of Regalis Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Regalis Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Regalis Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Regalis Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Regalis Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAHCR9024K1Z9 | Chhattisgarh | Active | 21 Jan 2021 |
To see the full GST registrations and return filing status of Regalis Life Sciences Private Limited, buy the company report.
Recent activity
Regalis Life Sciences Private Limited has 7 board changes on record since 2016: 3 appointments and 4 cessations. The latest: Ashish Chopda ceased to be Additional Director on 30 Dec 2020.
Frequently asked questions
Regalis Life Sciences is an active private limited company based in Raipur, Chhattisgarh, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 05 July 2016 (10+ years old) and is registered under CIN U24304CT2016PTC007375.
Regalis Life Sciences has 3 current directors:
- Komal Chand Chopda - Director
- Rishabh Chopda - Director
- Ashish Chopda - Director
The latest financial statements of Regalis Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Regalis Life Sciences is 22AAHCR9024K1Z9, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Regalis Life Sciences is U24304CT2016PTC007375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Regalis Life Sciences was incorporated on 05 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
Ashish Chopda ceased to be Additional Director on 30 Dec 2020. Rishabh Chopda ceased to be Additional Director on 30 Dec 2020. Chandrashekhar Dubey Rishideo ceased to be Additional Director on 25 Feb 2020. Regalis Life Sciences has 7 board changes on record in total.
The registered office of Regalis Life Sciences is at Plot No.11 Kedia Business Park Opposite National Garage Tatibandh, Raipur, Chhattisgarh, India – 492001.
Regalis Life Sciences operates in the healthcare industry, in the medical equipment retail and distribution segment.
The compliance status of Regalis Life Sciences is compliant as of 04 September 2026. The company is actively filing with the Registrar of Companies.